Physician

Eric Luk, M.D.

According to 2025 Medicare claims, Eric Luk, M.D. (NPI: 1992125934) practices hematology/oncology in the Asheville, NC market, with the plurality of this provider's patient population coming from Buncombe, NC. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 28806-2316. Luk is affiliated with the Mission Health Partners, LLC (ACO ID: A2591) and AdvantagePoint Health Alliance - Western North Carolina, LLC (ACO ID: A5039), participating under the MSSP model.

Luk's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 888 traditional Medicare patients, billed 127,748 HCPCS/CPT codes, and received $2,857,540 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,330 prescription claims across 222 beneficiaries totaling $2,714,444 in drug costs, led by Revlimid (Lenalidomide). DME data shows 151 claims. Open Payments data shows 52 records totaling $2,237. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $9,947 to $2,857,540. Similarly, Part D prescription costs have moved sharply higher in recent years, from $6,193 to $2,714,444. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,669 and ending at $5,907.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.9M2020 Medicare payment: $9,947 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $53,126 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $38,212 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,688,123 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,857,540 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
202046108$9,947
2021176514$53,126
2022153381$38,212
202370585,273$1,688,123
2024888127,748$2,857,540

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.4M$2.7M2015 Drug cost: $6,193 (USD; Tot_Drug_Cst)2016 Drug cost: $7,645 (USD; Tot_Drug_Cst)2017 Drug cost: $19,499 (USD; Tot_Drug_Cst)2018 Drug cost: $149,462 (USD; Tot_Drug_Cst)2019 Drug cost: $256,522 (USD; Tot_Drug_Cst)2020 Drug cost: $263,340 (USD; Tot_Drug_Cst)2021 Drug cost: $501,392 (USD; Tot_Drug_Cst)2022 Drug cost: $1,743,114 (USD; Tot_Drug_Cst)2023 Drug cost: $1,354,947 (USD; Tot_Drug_Cst)2024 Drug cost: $2,714,444 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201566235$6,193
201646124$7,645
201743150$19,499
201882261$149,462
201927205$256,522
202048305$263,340
20211571,070$501,392
20222271,548$1,743,114
2023203804$1,354,947
20242221,330$2,714,444

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$61K$123K2015 Medicare payment: $3,648 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $122,537 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,240 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $5,562 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R11$3,648
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/R106$122,537
2022N/R47$1,240
2023N/RN/RN/R
2024N/R151$5,562

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more157325$127
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more197269$87
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's227412$12
36415Insertion of needle into vein for collection of blood sample534996$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count5641,099$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide451,253$728,231
LenalidomideLenalidomide17476$269,589
XtandiEnzalutamide16480$221,196
TagrissoOsimertinib Mesylate11330$187,683
GilotrifAfatinib Dimaleate11330$126,895

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R23$1,818
J8700Temozolomide, oral, 5 mgNN/R16$1,512
J8521Capecitabine, oral, 500 mgNN/R16$701
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R29$546
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R30$451

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.52$2,237AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Eric Luk, M.D.?

Tedicare shows public-source Medicare data for Eric Luk, M.D. (NPI 1992125934), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Eric Luk, M.D. have ACO affiliation data?

Eric Luk, M.D. is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591) and AdvantagePoint Health Alliance - Western North Carolina, LLC (MSSP, ACO ID A5039).

What billing organization is linked to Eric Luk, M.D.?

Eric Luk, M.D. is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Eric Luk, M.D. have Open Payments data?

Eric Luk, M.D. has 52 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.